Hjem › Hyperthyreose › Maryland
Hyperthyreose kliniske forsøg i Maryland
3 studier for Hyperthyreose søger deltagere på steder i Maryland.
Officiel studietekst (engelsk)
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old
- Patient First Clinical Trials (PFCTrials), Lutherville
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 2. okt. 2026 · NCT07722546Natural History of Thyroid Function Disorders
- National Institutes of Health Clinical Center, Bethesda
RekruttererObservationsstudie
6 Months – 98 Years · Alle køn · Opdateret 16. sep. 2026 · NCT00001159A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
- Site Number - 1023, Baltimore
RekruttererFase 2
Alder 18 til 75 · Alle køn · Opdateret 25. aug. 2026 · NCT06727604Fra ClinicalTrials.gov, data hentet 3. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.